Skip to content

Acquisitions at other companies

Agrify Corporation logo
Agrify CorporationRYM
$3.1M+300%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$1.25M0.0%
Opko Health logo
Opko HealthOPK
$0-100%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$379.25K

Other financials

Income statement

See full
Revenue$206.7M+11.3%
Gross profit$55.0M+5.7%
Operating income-$26.4M+96.5%
Net income-$26.6M+96.6%
EPS (diluted)-$0.24+97.2%

Balance sheet

See full
Cash & equivalents$204.6M+2.3%
Total debt$211.4M-6.9%
Total equity$1.6B-42.9%
Total assets$2.1B-39.0%

Cash flow

See full
Operating cash flow-$21.9M-281%
CapEx$6.3M-34.8%
Free cash flow-$19.1M

Valuation

See full
Market cap$542.47M+34.5%
Enterprise value$549.21M+34.2%
P/S0.6×+0.1×

Profitability

See full
Gross margin30.9%+2.9pp
Operating margin-103.5%-198pp
Net margin-156.1%+89.5pp
FCF margin-15.5%

Returns & leverage

See full
Return on equity-62.5%-1,636pp
Debt / equity0.1×+0.1×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Tilray Brands, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Tilray Brands, Inc.’s 10-Q, filed April 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tilray Brands, Inc.'s acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tilray Brands, Inc.'s acquisitions?
Tilray Brands, Inc. (TLRY) reported acquisitions of $0 in Q4 2025.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.